Curadis Competitors and Similar CompaniesClear all
Orexo's competitors and similar companies include Imvax and Siloam.
 Orexo Orexo, a specialty pharmaceutical company, engages in the development and commercialization of drugs. |  Imvax Imvax is a biotechnology company that develops vaccines and immunotherapy strategies for the treatment of malignant gliomas and other cancers. | ||
Founding Date | Founding Date 1995 | Founding Date 2015 | Founding Date 1996 |
Type | Type Public | Type Private | Type Public |
Tags | |||
Locations | Locations Uppsala, SE HQ Uppsala, SE Morristown, US | Locations Philadelphia, US HQ | Locations ID HQ |
Employees | Employees 110 | Employees 2723% decrease | Employees 14,616 |
Financial | |||
Revenue (est.) | Revenue (est.) kr26m (FY, 2025) | Revenue (est.) N/A | Revenue (est.) Rp12.8t (FY, 2025) |
Cost of goods | Cost of goods kr14.5m (FY, 2025) | Cost of goods N/A | Cost of goods Rp7.7t (FY, 2025) |
Gross profit | Gross profit kr18m (FY, 2025) | Gross profit N/A | Gross profit Rp5.2t (FY, 2025) |
Net income | Net income (kr403.3m) (FY, 2025) | Net income N/A | Net income Rp1.2t (FY, 2025) |
Funding | |||
Total funding raised | Total funding raised $ 72.9m | Total funding raised $ 166.7m | Total funding raised N/A |
For sources of this data, please see the company profile
View Company Profiles
Imvax
HQ
Philadelphia, US
Employees
27↓ 23% decrease
Imvax is a biotechnology company that develops vaccines and immunotherapy strategies for the treatment of malignant gliomas and other cancers.
View company